IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price
on Aug 13, 2025
IGM Biosciences Employees
IGM Biosciences had 149 employees as of December 31, 2024. The number of employees decreased by 75 or -33.48% compared to the previous year.
Employees
149
Change (1Y)
-75
Growth (1Y)
-33.48%
Revenue / Employee
$9,065,625
Profits / Employee
-$3,336,563
Market Cap
n/a
Employees Chart
IGMS News
- 5 months ago - IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right - GlobeNewsWire
- 11 months ago - IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out - Market Watch
- 11 months ago - IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs - GlobeNewsWire
- 1 year ago - IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - IGM Biosciences to Present at Three Upcoming Investor Conferences - GlobeNewsWire
- 1 year ago - IGM Biosciences' stock tumbles as analysts weigh in on pivot plan with dismay - Market Watch
- 1 year ago - IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO - Benzinga
- 1 year ago - IGM Biosciences Stock Drops 27% on ‘Pipeline Transformation' to Autoimmune Diseases - Barrons